MENACTRA 0.5ML SOL. FOR I.M. INJ. 5 VIAL

MENACTRA IS INDICATED FOR ACTIVE IMMUNIZATION TO PREVENT INVASIVE MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUPS A C Y AND W-135. MENACTRA IS APPROVED FOR USE IN INDIVIDUALS 9 MONTHS THROUGH 55 YEARS OF AGE. MENACTRA DOES NOT PREVENT N MENINGITIDIS SEROGROUP B DISEASE. A SINGLE BOOSTER DOSE OF MENACTRA MAY BE GIVEN TO INDIVIDUALS 15-55 YEARS OF AGE AT CONTINUED RISK FOR MENINGOCOCCAL DISEASE IF AT LEAST 4 YEARS HAVE ELAPSED SINCE THE PRIOR DOSE.